Upload Avatar (500 x 500)
Zhiqian Tong
Psychiatry
Wenzhou Medical University
Zhejiang
Language: Chinese, English
Alzheimer'S Disease
Pathogenesis
Photoelectric Therapy
Nano Drugs
Neurodegenerative
Cognitive Impairment
Red Light Therapy
Nano Coenzyme Q10
Brain Disorders
Aging
Areas of Focus
- Pathogenesis of Alzheimer's Disease
- Development of Photoelectric Therapy Devices
- Development of Nano Drugs
Work Experience
- 2021-present - Wenzhou Medical University - Professor at the Institute of Geriatric Diseases
- 2014-2020 - Capital Medical University Beijing Institute for Brain Disorders - Associate Researcher
- 2008-2013 - Chinese Academy of Sciences Institute of Biophysics - Postdoctoral Research
Academic Background & Achievements
- 2004-2008 PhD: Peking University Institute of Medical Neurosciences
- Postdoctoral Research: Chinese Academy of Sciences Institute of Biophysics, State Key Laboratory of Brain and Cognitive Sciences
- Developed high-energy nano red light therapy device and nano coenzyme Q10
Publications
- Degradation of FA reduces Aβ neurotoxicity and Alzheimer-related phenotypes, Xuechao Fei, et al, Weihong Song*, and Zhiqian Tong*, 2020
- Single point mutation from E22-to-K in Aβ initiates early-onset Alzheimer’s disease by binding with catalase, Wenjing Jiang, et al, Jihui Lyu*, and Zhiqian Tong*, 2020
- Illumination with 630-nm red light reduces oxidative stress and restores memory by photo-activating catalase and formaldehyde dehydrogenase in SAMP8 mice, Jingnan Zhang, et al, Zhiqian Tong*, 2019
- Formaldehyde induces diabetes-associated cognitive impairments, Tao Tan, et al. Weihong Song*, and Zhiqian Tong*, 2018
- Aging-associated formaldehyde-induced norepinephrine deficiency contributes to age-related memory decline, Yufei Mei, et al. Tong Z*, 2015
Awards
- 2020 Chinese Medical Science and Technology Second Prize
